The zebrafish disease and drug screening model : A strong ally against Covid-19
| dc.contributor.author | Galindo-Villegas, Jorge | |
| dc.date.accessioned | 2020-07-20T09:45:19Z | |
| dc.date.available | 2020-07-20T09:45:19Z | |
| dc.date.created | 2020-05-05T01:09:09Z | |
| dc.date.issued | 2020 | |
| dc.identifier.citation | Galindo-Villegas, J. (2020). The zebrafish disease and drug screening model: A strong ally against Covid-19. Frontiers in Pharmacology, 11: 680. doi: | en_US |
| dc.identifier.issn | 1663-9812 | |
| dc.identifier.uri | https://hdl.handle.net/11250/2669697 | |
| dc.language.iso | eng | en_US |
| dc.publisher | Frontiers | en_US |
| dc.rights | Navngivelse 4.0 Internasjonal | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/deed.no | * |
| dc.title | The zebrafish disease and drug screening model : A strong ally against Covid-19 | en_US |
| dc.type | Peer reviewed | en_US |
| dc.type | Journal article | en_US |
| dc.description.version | publishedVersion | en_US |
| dc.rights.holder | © 2020 The Author(s) | en_US |
| dc.subject.nsi | VDP::Medisinske Fag: 700::Basale medisinske, odontologiske og veterinærmedisinske fag: 710::Farmakologi: 728 | en_US |
| dc.source.pagenumber | 2 | en_US |
| dc.source.volume | 11 | en_US |
| dc.source.journal | Frontiers in Pharmacology | en_US |
| dc.identifier.doi | 10.3389/fphar.2020.00680 | |
| dc.identifier.cristin | 1809337 | |
| dc.description.localcode | Unit Licence Agreement | en_US |
| cristin.qualitycode | 1 |
Tilhørende fil(er)
Denne innførselen finnes i følgende samling(er)
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal